Gambling, Resorts & Casinos
Compare Stocks
5 / 10Stock Comparison
GAMB vs RILY vs GENI vs SRAD vs DKNG
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Conglomerates
Internet Content & Information
Software - Application
Gambling, Resorts & Casinos
GAMB vs RILY vs GENI vs SRAD vs DKNG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Gambling, Resorts & Casinos | Financial - Conglomerates | Internet Content & Information | Software - Application | Gambling, Resorts & Casinos |
| Market Cap | $155M | $305M | $1.17B | $4.04B | $12.50B |
| Revenue (TTM) | $155M | $1.03B | $669M | $1.33B | $6.05B |
| Net Income (TTM) | $2M | $531M | $-112M | $70M | $4M |
| Gross Margin | 93.2% | 65.0% | 22.9% | 38.2% | 41.3% |
| Operating Margin | 2.6% | 14.6% | -18.1% | 9.3% | -0.2% |
| Forward P/E | 8.6x | 1.1x | 52.4x | 33.1x | 99.1x |
| Total Debt | $28M | $1.47B | $30M | $63M | $1.93B |
| Cash & Equiv. | $14M | $227M | $281M | $365M | $1.60B |
GAMB vs RILY vs GENI vs SRAD vs DKNG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| Gambling.com Group … (GAMB) | 100 | 48.4 | -51.6% |
| BRC Group Holdings,… (RILY) | 100 | 14.7 | -85.3% |
| Genius Sports Limit… (GENI) | 100 | 25.5 | -74.5% |
| Sportradar Group AG (SRAD) | 100 | 60.3 | -39.7% |
| DraftKings Inc. (DKNG) | 100 | 52.4 | -47.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GAMB vs RILY vs GENI vs SRAD vs DKNG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GAMB is the clearest fit if your priority is long-term compounding.
- -44.7% 10Y total return vs RILY's 239.7%
RILY carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (1.1x vs 99.1x)
- 29.8% margin vs GENI's -16.7%
- +210.4% vs GAMB's -66.9%
- 31.3% ROA vs GENI's -11.1%, ROIC 8.3% vs -16.6%
GENI is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 1 yrs, beta 1.50
- 31.0% revenue growth vs RILY's -11.5%
SRAD ranks third and is worth considering specifically for sleep-well-at-night and defensive.
- Lower volatility, beta 0.65, Low D/E 6.4%, current ratio 1.17x
- Beta 0.65, current ratio 1.17x
- Beta 0.65 vs RILY's 2.03
DKNG is the clearest fit if your priority is growth exposure.
- Rev growth 27.0%, EPS growth 99.2%, 3Y rev CAGR 39.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 31.0% revenue growth vs RILY's -11.5% | |
| Value | Lower P/E (1.1x vs 99.1x) | |
| Quality / Margins | 29.8% margin vs GENI's -16.7% | |
| Stability / Safety | Beta 0.65 vs RILY's 2.03 | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +210.4% vs GAMB's -66.9% | |
| Efficiency (ROA) | 31.3% ROA vs GENI's -11.1%, ROIC 8.3% vs -16.6% |
GAMB vs RILY vs GENI vs SRAD vs DKNG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
GAMB vs RILY vs GENI vs SRAD vs DKNG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GAMB leads in 2 of 6 categories
RILY leads 1 • GENI leads 1 • SRAD leads 0 • DKNG leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — RILY and DKNG each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DKNG is the larger business by revenue, generating $6.1B annually — 39.2x GAMB's $155M. RILY is the more profitable business, keeping 29.8% of every revenue dollar as net income compared to GENI's -16.7%. On growth, DKNG holds the edge at +42.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $155M | $1.0B | $669M | $1.3B | $6.1B |
| EBITDAEarnings before interest/tax | $20M | $390M | -$50M | $308M | $266M |
| Net IncomeAfter-tax profit | $2M | $531M | -$112M | $70M | $4M |
| Free Cash FlowCash after capex | $39M | $180M | $37M | $363M | $612M |
| Gross MarginGross profit ÷ Revenue | +93.2% | +65.0% | +22.9% | +38.2% | +41.3% |
| Operating MarginEBIT ÷ Revenue | +2.6% | +14.6% | -18.1% | +9.3% | -0.2% |
| Net MarginNet income ÷ Revenue | +1.2% | +29.8% | -16.7% | +5.2% | +0.1% |
| FCF MarginFCF ÷ Revenue | +25.3% | -6.9% | +5.5% | +27.3% | +10.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +21.4% | — | +37.0% | +13.2% | +42.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -145.8% | +100.0% | +33.8% | -128.5% | +192.9% |
Valuation Metrics
GAMB leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 1.1x trailing earnings, RILY trades at a 97% valuation discount to SRAD's 38.7x P/E. On an enterprise value basis, GAMB's 4.1x EV/EBITDA is more attractive than DKNG's 49.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $155M | $305M | $1.2B | $4.0B | $12.5B |
| Enterprise ValueMkt cap + debt − cash | $170M | $1.5B | $924M | $3.7B | $12.8B |
| Trailing P/EPrice ÷ TTM EPS | 5.26x | 1.14x | -10.83x | 38.69x | -3113.58x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.63x | — | 52.42x | 33.09x | 99.14x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.68x | — |
| EV / EBITDAEnterprise value multiple | 4.09x | 8.33x | — | 17.74x | 49.42x |
| Price / SalesMarket cap ÷ Revenue | 1.22x | 0.30x | 1.75x | 2.77x | 2.06x |
| Price / BookPrice ÷ Book value/share | 1.30x | — | 1.68x | 3.79x | 19.81x |
| Price / FCFMarket cap ÷ FCF | 40.77x | — | 18.18x | 8.98x | 19.31x |
Profitability & Efficiency
GAMB leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
SRAD delivers a 7.3% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-16 for GENI. GENI carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to DKNG's 3.06x. On the Piotroski fundamental quality scale (0–9), GAMB scores 7/9 vs GENI's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.4% | — | -15.5% | +7.3% | +0.5% |
| ROA (TTM)Return on assets | +0.7% | +31.3% | -11.1% | +2.7% | +0.1% |
| ROICReturn on invested capital | +23.0% | +8.3% | -16.6% | +12.9% | -0.9% |
| ROCEReturn on capital employed | +26.3% | +10.2% | -15.3% | +5.3% | -0.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 | 3 | 4 | 7 |
| Debt / EquityFinancial leverage | 0.23x | — | 0.04x | 0.06x | 3.06x |
| Net DebtTotal debt minus cash | $14M | $1.2B | -$250M | -$302M | $330M |
| Cash & Equiv.Liquid assets | $14M | $227M | $281M | $365M | $1.6B |
| Total DebtShort + long-term debt | $28M | $1.5B | $30M | $63M | $1.9B |
| Interest CoverageEBIT ÷ Interest expense | 1.79x | 10.78x | -136.57x | 2.02x | 1.92x |
Total Returns (Dividends Reinvested)
RILY leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GAMB five years ago would be worth $5,525 today (with dividends reinvested), compared to $2,536 for GENI. Over the past 12 months, RILY leads with a +210.4% total return vs GAMB's -66.9%. The 3-year compound annual growth rate (CAGR) favors GENI at 5.5% vs RILY's -29.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -16.4% | +67.8% | -55.8% | -41.5% | -29.3% |
| 1-Year ReturnPast 12 months | -66.9% | +210.4% | -53.1% | -41.4% | -27.3% |
| 3-Year ReturnCumulative with dividends | -55.6% | -65.6% | +17.4% | +5.7% | +4.3% |
| 5-Year ReturnCumulative with dividends | -44.8% | -64.6% | -74.6% | -45.5% | -47.9% |
| 10-Year ReturnCumulative with dividends | -44.7% | +239.7% | -52.4% | -45.5% | +157.3% |
| CAGR (3Y)Annualised 3-year return | -23.7% | -29.9% | +5.5% | +1.9% | +1.4% |
Risk & Volatility
Evenly matched — RILY and SRAD each lead in 1 of 2 comparable metrics.
Risk & Volatility
SRAD is the less volatile stock with a 0.65 beta — it tends to amplify market swings less than RILY's 2.03 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RILY currently trades 79.2% from its 52-week high vs GAMB's 29.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.38x | 2.03x | 1.50x | 0.65x | 1.12x |
| 52-Week HighHighest price in past year | $14.95 | $10.97 | $13.73 | $32.22 | $48.78 |
| 52-Week LowLowest price in past year | $3.51 | $2.75 | $3.83 | $11.66 | $20.46 |
| % of 52W HighCurrent price vs 52-week peak | +29.6% | +79.2% | +34.7% | +42.3% | +51.7% |
| RSI (14)Momentum oscillator 0–100 | 61.4 | 65.8 | 45.3 | 38.7 | 55.1 |
| Avg Volume (50D)Average daily shares traded | 559K | 820K | 5.6M | 3.6M | 12.9M |
Analyst Outlook
GENI leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: GAMB as "Buy", RILY as "Hold", GENI as "Buy", SRAD as "Buy", DKNG as "Buy". Consensus price targets imply 153.9% upside for GENI (target: $12) vs 46.2% for DKNG (target: $37).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $7.00 | — | $12.10 | $21.75 | $36.88 |
| # AnalystsCovering analysts | 8 | 1 | 19 | 20 | 48 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 0 | 1 | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +17.4% | 0.0% | 0.0% | +2.9% | +6.6% |
GAMB leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). RILY leads in 1 (Total Returns). 2 tied.
GAMB vs RILY vs GENI vs SRAD vs DKNG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GAMB or RILY or GENI or SRAD or DKNG a better buy right now?
For growth investors, Genius Sports Limited (GENI) is the stronger pick with 31.
0% revenue growth year-over-year, versus -11. 5% for BRC Group Holdings, Inc. (RILY). BRC Group Holdings, Inc. (RILY) offers the better valuation at 1. 1x trailing P/E, making it the more compelling value choice. Analysts rate Gambling. com Group Limited (GAMB) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GAMB or RILY or GENI or SRAD or DKNG?
On trailing P/E, BRC Group Holdings, Inc.
(RILY) is the cheapest at 1. 1x versus Sportradar Group AG at 38. 7x. On forward P/E, Gambling. com Group Limited is actually cheaper at 8. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — GAMB or RILY or GENI or SRAD or DKNG?
Over the past 5 years, Gambling.
com Group Limited (GAMB) delivered a total return of -44. 8%, compared to -74. 6% for Genius Sports Limited (GENI). Over 10 years, the gap is even starker: RILY returned +239. 7% versus GENI's -52. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GAMB or RILY or GENI or SRAD or DKNG?
By beta (market sensitivity over 5 years), Sportradar Group AG (SRAD) is the lower-risk stock at 0.
65β versus BRC Group Holdings, Inc. 's 2. 03β — meaning RILY is approximately 210% more volatile than SRAD relative to the S&P 500. On balance sheet safety, Genius Sports Limited (GENI) carries a lower debt/equity ratio of 4% versus 3% for DraftKings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GAMB or RILY or GENI or SRAD or DKNG?
By revenue growth (latest reported year), Genius Sports Limited (GENI) is pulling ahead at 31.
0% versus -11. 5% for BRC Group Holdings, Inc. (RILY). On earnings-per-share growth, the picture is similar: Sportradar Group AG grew EPS 200. 0% year-over-year, compared to -63. 0% for Genius Sports Limited. Over a 3-year CAGR, GAMB leads at 44. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GAMB or RILY or GENI or SRAD or DKNG?
BRC Group Holdings, Inc.
(RILY) is the more profitable company, earning 29. 8% net margin versus -16. 7% for Genius Sports Limited — meaning it keeps 29. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GAMB leads at 28. 1% versus -15. 6% for GENI. At the gross margin level — before operating expenses — GAMB leads at 94. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GAMB or RILY or GENI or SRAD or DKNG more undervalued right now?
On forward earnings alone, Gambling.
com Group Limited (GAMB) trades at 8. 6x forward P/E versus 99. 1x for DraftKings Inc. — 90. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GENI: 153. 9% to $12. 10.
08Which pays a better dividend — GAMB or RILY or GENI or SRAD or DKNG?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is GAMB or RILY or GENI or SRAD or DKNG better for a retirement portfolio?
For long-horizon retirement investors, Sportradar Group AG (SRAD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
65)). BRC Group Holdings, Inc. (RILY) carries a higher beta of 2. 03 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SRAD: -45. 5%, RILY: +239. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GAMB and RILY and GENI and SRAD and DKNG?
These companies operate in different sectors (GAMB (Consumer Cyclical) and RILY (Financial Services) and GENI (Communication Services) and SRAD (Technology) and DKNG (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: GAMB is a small-cap high-growth stock; RILY is a small-cap deep-value stock; GENI is a small-cap high-growth stock; SRAD is a small-cap quality compounder stock; DKNG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 18%
- Gross Margin > 13%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.